NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001786

Registered date:19/03/2009

Intravenous micafungin versus intravenous voriconazole for chronic necrotizing pulmonary aspergillosis: a multicenter, open-labeled, non-inferiority trial in Japan

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedChronic necrotizing pulmonary aspergillosis
Date of first enrollment2006/04/01
Target sample size150
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Administration of antifungal drugs (MCFG) Administration of antifungal drugs (VRCZ)

Outcome(s)

Primary OutcomeEfficacy of drugs after administration of two weeks
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaThe following patients were excluded from the study: (1) patients received MCFG or VRCZ within a month at the time of the diagnosis of CNPA, (2) patients with simple aspergilloma, invasive pulmonary aspergillosis, or allergic bronchopulmonary aspergillosis, (3) patients with infectious diseases other than Aspergillosis, (4) pregnant patients, (5) patients without informed consent, and (6) patients with liver, kidney and heart failure (more than Grade II in CTCAEv3.0).

Related Information

Contact

public contact
Name Koichi Izumikawa
Address Japan
Telephone
E-mail koizumik@nagasaki-u.ac.jp
Affiliation Nagasaki University Graduate School of Biomedical Sciences Department of Molecular Microbiology and Immunology
scientific contact
Name Shigeru Kohno
Address 1-7-1 Sakamoto, Nagasaki 852-8501, JAPAN Japan
Telephone
E-mail
Affiliation Nagasaki University Graduate School of Biomedical Sciences Department of Molecular Microbiology and Immunology